PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
5. September 2024

ESC Congress 2024: Powerful Medical Unveils Novel AI Cardiology Research on the Global Stage

ESC 2024 - blog cover

Our experience at ESC Congress 2024 in London, organized by the European Society of Cardiology, was nothing short of remarkable. The PMcardio booth buzzed with excitement as we showcased our cutting-edge AI technology to the global cardiology community, eager to explore the future of cardiac care.

ESC congress 2024

PMcardio Booth Highlights and Industry Engagement

At our booth in the digital health area, we were thrilled by the high traffic and the enthusiasm around AI-powered diagnostics. The conversations were dynamic and insightful, reflecting a growing interest in the real-world implementation of AI in hospital settings. We were honored to have ECG experts Dr. Stephen Smith and Dr. Pendell Meyers with us at the PMcardio booth.

ESC congress 2024
ESC congress 2024
ESC congress 2024

Their presence highlighted our strong collaboration with these world-class experts, for which we are deeply grateful. We were thrilled to connect in person with clinical teams from institutions we are already actively collaborating with, strengthening our existing partnerships. Additionally, we forged new relationships within the cardiology community, paving the way for exciting future collaborations.

ESC 2024
ESC 2024
ESC congress 2024
ESC congress 2024
ESC congress 2024

Dr. Robert Herman’s Presentation: Revolutionizing Acute Coronary Occlusion Detection

A highlight for Powerful Medical at ESC Congress 2024 was Dr. Robert Herman’s presentation on the Digital Health Stage. His talk, titled “International Evaluation of an AI-Powered ECG Model Detecting Acute Coronary Occlusion in Myocardial Infarction,” was featured in the “Top Publications in the European Heart Journal – Digital Health” session.

A highlight of the program at the Digital Health Stage was the presentation by our Chief Medical Officer, Dr. Robert Herman, titled “International Evaluation of an AI-Powered ECG Model Detecting Acute Coronary Occlusion in Myocardial Infarction”. Featured as part of the “Top Publications in the European Heart Journal – Digital Health” session, this talk was an excellent opportunity to demonstrate how our AI technology advances the detection of acute myocardial infarction beyond traditional diagnostic criteria.

International evaluation of an AI-powered ECG model detecting acute coronary occlusion in MI | ESC

This presentation underscored our successful clinical research collaboration with Cardiovascular Center Aalst, aimed at improving the timely detection of heart attacks right at the first point of patient contact and augmenting the chest pain patient pathway with artificial intelligence. The diagnostic performance of the PMcardio AI model, published in the European Heart Journal – Digital Health, demonstrated outstanding performance with an AUC of 0.938, an accuracy of 90.9%, sensitivity of 80.6%, and specificity of 93.7%.

ESC Congress 2024: Powerful Medical Unveils Novel AI Cardiology Research on the Global Stage
ESC Congress 2024: Powerful Medical Unveils Novel AI Cardiology Research on the Global Stage
ESC Congress 2024: Powerful Medical Unveils Novel AI Cardiology Research on the Global Stage

These results surpass the traditional STEMI criteria and closely match the expertise of seasoned ECG professionals. Already in use in clinical practice, this AI model is enhancing the rapid and accurate detection of acute coronary occlusions, leading to better patient outcomes and more efficient patient triage. 

Dr. Anthony Demolder’s Presentation: Addressing the Heart Failure Crisis

Another key highlight of the program was Dr. Anthony Demolder’s presentation on our groundbreaking research titled “A smartphone-based AI model to detect left ventricular systolic dysfunction on 12-lead ECG.” This study was presented during the “Advances In Science” session on the Digital Health Stage.

A smartphone-based AI model to detect left ventricular systolic dysfunction on ECG | ESC London 2024

Dr. Demolder emphasized the pressing issue of heart failure, which affects millions worldwide and imposes a massive economic burden on healthcare systems. Our PMcardio AI model, capable of detecting reduced left ventricular ejection fraction (LVEF) with an AUC >0.95 and a sensitivity of 90%, offers a revolutionary approach to early detection. This could dramatically reduce mortality rates and ease financial strains by cutting down on hospitalizations and enabling timely interventions.

Looking Ahead to ESC Congress 2025

We extend our heartfelt thanks to everyone who visited us at our booth in London. The energy and enthusiasm at the ESC Congress 2024 have invigorated us, and we are more committed than ever to advancing the field of cardiology through innovative AI solutions. We’re already looking forward to the next ESC Congress in 2025 in Madrid, where we plan to share even more groundbreaking advancements. See you there!

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

May was a milestone month at Powerful Medical. From launching PMcardio for Individuals 3.0 and showcasing new explainable AI tools, to advancing STEMI detection through international research and clinical collaboration—discover the breakthroughs that are shaping the future of cardiac care.
Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

PMcardio has long been a trusted diagnostic companion to over 100,000 providers worldwide—from emergency departments and clinics to rural ambulances and primary care offices. With the launch of PMcardio for Individuals 3.0, we’re raising the bar once again—delivering instant, explainable AI support for ECG interpretation, empowering faster, more confident decisions in acute cardiovascular care settings.

Join over 100,000 healthcare professionals who are already taking advantage of AI